Advances in the Development of Antiviral Compounds for Rotavirus Infections
Group A rotaviruses (RVAs) are the major cause of severe acute gastroenteritis (AGE) in children under 5 years of age, annually resulting in nearly 130,000 deaths worldwide. Social conditions in developing countries that contribute to decreased oral rehydration and vaccine efficacy and the lack of...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c4f9acf65eb1487e8b511935630f3f91 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c4f9acf65eb1487e8b511935630f3f91 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c4f9acf65eb1487e8b511935630f3f912021-11-03T21:15:05ZAdvances in the Development of Antiviral Compounds for Rotavirus Infections2150-751110.1128/mBio.00111-21https://doaj.org/article/c4f9acf65eb1487e8b511935630f3f912021-06-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00111-21https://doaj.org/toc/2150-7511 Group A rotaviruses (RVAs) are the major cause of severe acute gastroenteritis (AGE) in children under 5 years of age, annually resulting in nearly 130,000 deaths worldwide. Social conditions in developing countries that contribute to decreased oral rehydration and vaccine efficacy and the lack of approved antiviral drugs position RVA as a global health concern.María Julieta TohméLaura Ruth DelguiAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 12, Iss 3 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Microbiology QR1-502 |
spellingShingle |
Microbiology QR1-502 María Julieta Tohmé Laura Ruth Delgui Advances in the Development of Antiviral Compounds for Rotavirus Infections |
description |
Group A rotaviruses (RVAs) are the major cause of severe acute gastroenteritis (AGE) in children under 5 years of age, annually resulting in nearly 130,000 deaths worldwide. Social conditions in developing countries that contribute to decreased oral rehydration and vaccine efficacy and the lack of approved antiviral drugs position RVA as a global health concern. |
format |
article |
author |
María Julieta Tohmé Laura Ruth Delgui |
author_facet |
María Julieta Tohmé Laura Ruth Delgui |
author_sort |
María Julieta Tohmé |
title |
Advances in the Development of Antiviral Compounds for Rotavirus Infections |
title_short |
Advances in the Development of Antiviral Compounds for Rotavirus Infections |
title_full |
Advances in the Development of Antiviral Compounds for Rotavirus Infections |
title_fullStr |
Advances in the Development of Antiviral Compounds for Rotavirus Infections |
title_full_unstemmed |
Advances in the Development of Antiviral Compounds for Rotavirus Infections |
title_sort |
advances in the development of antiviral compounds for rotavirus infections |
publisher |
American Society for Microbiology |
publishDate |
2021 |
url |
https://doaj.org/article/c4f9acf65eb1487e8b511935630f3f91 |
work_keys_str_mv |
AT mariajulietatohme advancesinthedevelopmentofantiviralcompoundsforrotavirusinfections AT lauraruthdelgui advancesinthedevelopmentofantiviralcompoundsforrotavirusinfections |
_version_ |
1718445420654362624 |